Coronary vasodilation is impaired in both hypertrophied and nonhypertrophied myocardium of patients with hypertrophic cardiomyopathy: A study with nitrogen-13 ammonia and positron emission tomography  by Camici, Paolo et al.
METHODS ~_____ - 
Coronary Vasodilation Is Impaired in Both Hypertrophied and 
Nonhypertrophied Myocardium of Patients With Hypertrophic 
Cardiomyopathy: A Study With Nitrogen-13 Ammor!ia and Positron 
Emission Tomography 
PAOLO CAMICI. MD, FACC,*t GIAHPAOLO CHIRIATTI. MD.+ ROBERTO LORENZONI. MD.’ 
RICCARDO C. BELLINA. MD.** ROBERTO GISTRI, MD,’ CiESSlCA ITALIANI. MD,I- 
OBERDAN PARODI. MD.’ PIER0 A. SALVADORI. PHD,* NICOLA NISTA,’ LAURO PAPI. MD,1 
ANTONIO L’ABBATE. MD. FACC*t 
PiSO, hly 
To asszw regmnat coronary reserve tn h>pertrophir ardiemyop 
athy, regkmat m,oenrdtt Mood (low was -“red tn 23 patteu 
with hypatmp?k epldimayopathy nod 12 cwtmt subjects by 
mtlm ef nitrogen-I3 ammonia and dynamic positron endsstan 
Lomaynphy. In patients ritb hypertrophie cardiomyopathy 
at b&tine study. regionat myocardtt btwd Om* was 1.14 f 
0.43 mUmtn per g in the k~lwmplded I20 t 3 mm) inter- 
ventrtadar septum and 0.90 + 0.35 mUtin per g tp c 0.05 
verse sq4al 00~) in tke noohyprtroptded I10 + 2 mm) 
kft wntricldar ,ree Walt. Tbxzw were wt rtatts”cauy dtterent 
from tbx wnqmndtng v&ws in control subjects (I.04 + 0.25 
ud 0.91 f 0.21 mllndn per g, respwtirety. p = NS). After 
phumsmlogienlls induwd cumwry vastdilation ldipyridamola 
0.56 mglkg tntmvenwsty ow 4 min). regtmmt m)ourdttl bkod 
llmv in pattwts with hyprtropht cardiomyopathy inawed 
st&icantty less than in o&rot subjects bolb in the septum 
(1.63 + 0.58 wsus 2.99 + 1.06 mtlmin per g, p < 0.001) and in 
the frpe watt 11.47 t 0.5Y *ersus 2.44 + 0.82 mt’tin per g, p < 
O.WI,. 
In addition, patients with byprtropbtc cxdiomyopatky who 
tad a history of cha( pGn lwl more prwounrrd impairmmd d 
caronary vx,dt,lfor ,eserve ti did those dtbwt a hldory al 
.ce,t pain. After dtp.&iamde, ccnmary tisirtmce in the septum 
decruud by 38% in p&&s without P history of chest psba, but 
decreased by only 14% in Slav with such a htnq tp < 0.05). 
Coronary resistance in :be free apll daaed by 45% in pattentr 
without and by 27% in ttw with P htstary of chert pain tp = 
0.06, 
Thrw results hew tbt, tn p&tents with hyprtropbic csrdio- 
myapathj, coronary vvodttw reserve b abnormal “ot only b 
the hjpertlnphied interwotrkulu septum, but nka in lb why- 
prtraphted i?ee wall of the kft ventrkk. Tki9 finding sugbests 
that tke reddudrm in cwwwy reane is not mrpsssri!y due to 
myucardial hypwtmpky, but may 6e a primary dekct. 
,, AIn Co” cwdia, 1991;,7:879-86! 
Hypertmphic cardiomyopathy is a genetically tranxn tied 
disease characterized by an inappropriate myocardial thick- 
ness. most often involving the mtcrven~r~cular septurr of a 
nondilated ventricle (II. Because of ihe rtrikmg pathu!ogx 
tindmgs. most of the research relawe to this drsease ha5 
been focused on the hypenvphic myocardium. A reduced 
coronary vasoddator recewe :n the ,cmmry of the great 
cardiac vein. which prcdominanrly drams blood from the 
anteroseptal region of the left ventricle.. bar been reported 
121. More recently. in hypenmpbic cardiomyopathy. mor- 
pholog,c abnarmaiities of cardiac muscle and intramural 
coronary an&s have beer. reported f?) in myocardial 
region5 with normal wall thickness. and diastolic wall motmn 
abnornalws have been demonstrated 14) in these regions. 
Funhermorc. Wagner et al. IS) reported an increased num- 
bcr of calcium antagonist receptors not only m the hypertro- 
phied septum. but also in the nonhypatmphied right atrium. 
Altogcthcr. these findings rug@ that in patients with 
hypenmphic cardiomyopathy. anatomic and functional ahnor- 
maimer of the myocardium and coronary bed are not necer- 
ranly asraciated with gross tissue hypertrophy (6). TO assess 
whether coron;uy wave is abnormal in nonhypenrophied 
myoca&m of patients with hypcnrophic cardiomyopathy. 
rcgmnal mywardial blood Row was measured by means of 
nitrogen- 13 ammonia and dynamic positron emission tomoga- 
phy at rett and after intravenous dipyridamole m control 
subjects and patients wilh asymmetric septal hyperlropy. 
Methods 
Study patient% P&‘nls wirk kyperrropkir coldiomyopo- 
rky. This group comirted of 16 men and 7 womfn who had 
an echccardiographic diagnosis of hypenrophic cardiomy- 
opathy (Table I). In each patient. the echccardiogrwhic 
diagnosis was bared on the demonslmtion of 6 hypenrophkd 
Dondilaled left ventricle in the absence of any cardiac or 
systemic disease that could produce ventricular hjpenropby. 
except for four patients who had associated arterial hyperten- 
sion lkatients IO. 16. 20 and 23. Table 2). In 21 of Ihe 23 
patients. myocardial hype-trophy was confined to the inlerven- 
wicular septum. The symptoms and echowdiogmphic findmgs 
in Ihe 23 patients are lisxd in Table 2. Nine of the 23 patients 
reponed a history of typical chw pain. Selcclive cornnay 
angiography in muhiple view, in 11 x nine patients demon- 
waled a normal coronaty uee in ;/I 
Cuntrof wbjfctr. Tbex in& ,:d four men and eight 
women evaluated for a chest pain 5~ ndrome (Table I). AU had 
a normal physical exam&ion. rest elecmnrdiogmm (ECG). 
chest X.my series. echoca&gmm and a twmal exercise 
sircs~ !est. None of the subjects in this group had arterial 
hypertension. All had normal coronary and left ventricular 
ao&rams. None of the patients from either group had dike 
tes mellitus or hyperlipidemia. All studier were perfumed in 
the absence of drug treatment after an appropkte period of 
phammcolegic washout. AU patients and convol subjects gave 
informed consent before entering the study. 
Study pmtoml. In all subjects. regional myowdial blood 
Row war measured at baseline study and afler an intwe- 
now infusion ofdipyridamole (0.56 m&g over4 min). Three 
ECG leads (V,. V,, and V,) were continuously monitored 
during the stay period and a complete I2 lead ECG was 
Table 2. Prevalence of Symptoms and Echocardiogaphk Findings in 23 Patients WirhHylrnmphic Cardiomyopalby 
recorded every minute during dipyridamole infuion and up 
u) IO min after the end of infurion. Blood pressure was 
measured every minute by a cuti sphygmomanometer during 
dipyridamole infusion and for IO min thereafter. 
Posttron emission tomography. The patient was pow 
tioned on the bed of our two nng ECAT III pornron 
tomograph (CT11 to iiwe the cemer of gravity of the left 
ventricle as close as posriLle to the center of both the anal 
and tranrarial fields of view. This machine provides three 
simultaneous sections two from the prm~ary planes and one 
frcm the interplaneL 
Before the emission study was pafoned. a circular ring 
source filled with about 2.5 mCt of galbum- was used for 
the blank and tnnsmirrion data acquts~t~on. A reclilinca~ 
transmission scan was used as a low resolution X-ray film to 
identify the heart profile. Thereafter. the tranrmt~rion scan 
was performed to measure the attenuation correction coef. 
ticients to he used for each line of response of the Gnogram. 
The patient’s pusition wth rcspec; 10 rhe camera wa( 
chxked by a cross-shaped low power laser beam and pen 
rwkcrs oil the patient’s skit. 
For each regional myocardial blood flow measurement. 
0.25 mCi/kg body weight of nitrogen-13 ammonia. prepared 
as reported elsewhere 17). was slowly infused iotrwenously 
over a period of IS to 20 s. Dynamic positron em~svon 
tomographic acquisition was staned simultaneously with the 
beginning of the injection of the tracer and a total of 28 
framer (I6 x 3. II x I2 and I x 300 sl were acquired over 
8 min. Quantitative analysis was performed on that of the 
three slices tiiat best encompassed the septum and the free 
wall of the left ventricle. 
Regional myocardial blood Row dunng hyperww C&I- 
lions was assessed by injecting nitrogen-t3 ammonia 4 mm 
after the end of dipyridamole infunon. The rate-pressure 
product was calculated as hean rare lime5 ~YSIOIIC blood 
&essure. and regional coronary r&lance ar mean artrrnl 
blood pressur? divided by wional myocardial blood ilow. 
Lk& analysis. Sinogr&were normalned according to 
the tomograph dinuniformity map. corrected for atlcnuarmn 
and then reconstructed with a trdnsaxial spatial rebolution of 
about Y mm (full width 21 half maximum). The sum of the 
rates of randoms and multiples related to each rinugram war 
used for dead time loss corrections 18). 
To minimize spillover from tbc wall and avoid the partnl 
volume effect. a small region of interest was draw wthin 
the left ventricular cavny. Sue and Thape of rhe region of 
inwcst were assessed on the last equdlhnum %an. The 
time-activity cun’e was computed inride the region of inter- 
est in the left ventricular cavity and data value: x:e rhea 
corrected for decay and dead time 10%. The tracer’s input 
function was computed by fitting the initial portion of the 
time-actwlly curve with a gamma vanate (91. To obtain 
Illll,,mPtll_ crlo* rlc,c.-t,nn nr ,I?* ,rh “.WTi?II1T %.,,I/ an,+ 
calculate the tissue activity from the lart 300 s frame. a 
dedicated corcpu:er program was developed (9). 
operator manually identifies two circular regions of interest. 
one for the determination of both the center of the left 
ventricular cavity and the size of the compolalion area and 
rhe other to exclude the right ventricle. A logical product is 
performed hewecn Ihc two regions of mterest and only the 
resultam area is “red for further wmput&on. 2) Taking the 
center of rotation as defined in step I. the area is divided 
counterclockww into 12 wedges of 5’ each. 31 Each wedge 
i$ divided into sectors t I pixel thick) from the center toward 
the penphery and an actiwy profile is extracted; activity 
values are corrected for decay and dead time loss and then 
averaged in cvuntds per ~0x1. 41 The peak activity ofeach 
profile and the overall maximal activity of the 72 profiles are 
determined: the operator then sets a threshold as percent of 
the maximal activity. 
5) The peak activity point for each profile i$ found. If the 
actiwty 1s greater than rhe selected threshold. the region 
corresponding to the left ventncular wall is determined, 
mcluding all poin:c ranging from 50% of peak activiry on one 
aide to 50% on the other. If the peak activity is less than the 
thwhold tfor example. ischemic region). the range ofpoints 
is extracted from the pre:.ic~r wedge, the average wall 
actwty of the wedge is thus determined. 6) The mean wall 
thlcknerr of each wedge is computed by multiplying the 
pixel we by the number of points used in step 4. The wall 
activity 15 dwded by a recovery coefficient as a function of 
the th!ckne,s to correct for partial volume effect. The 
recovery function has been previously determined using a 
circular ecvzntric heart phantom (9). 71 The wall aclivily is 
awaged packing 19 x 9) the 72 wedges into six to eight 
region3 of mteresl la-cording to the configuration of the 
!o~o~rrml. encompassing the septum and the anterior and 
free wall of rhe left veericle. Mean septal and free wall 
activity wa> calculated by averaging the coonts of the 
relawe regions of interest. 
Regional myocardtal blood Row (RMBFI times nitro- 
gen-l; hmmuniarxtraction (RMBFe) WIP calculated accord- 
iag to the equation: 
cm.60 
RMBFe = -, 
I 
1 Cd0 dt 
where C, and C&t1 are nitrogen-13 aclivitjj concentrations 
tcountsl, per vowel) in the myocardium (obtained from the 
last scan &xorded from 3 to 8 minJ and in anerial blood at 
ttme I, respectively. The function Cb!t) was ritted by a 
gamma variate before integration (9). The final RMBFe 
:,3!x: zern rxpzzt? I: *:““.~!‘z!ll per x10! or zL’!zie per 
ml and then converted to mllmin pr g dividing by tissue 
gravitv (I .08 e/mll. 
uvng an equalion obtained in dogs from the relation between 
RMBFe laitrogen-I3 ammonia) and actual regional myocdr- 
dnal blood Row (meawred with radioactive microspheres) 
A xner of po\ilrun emirwn tomographrc rrneges ob- 
lamed at havlme %ludy and after drpyridamole infuslon m a 
con~rnl whjccr and in two palicnl* wilh hypenrophrc cw 
dmmyopathy arc <how in Fir.ure I. 
Baseline values. Al bawline \!udy. rcg~onal myocardial 
blood Row rn the conlrol wbjccts wa\ 1.04 f 0.25 mllmin 
per g rn the inlcrwnlricular ~eplun and 0.91 2 0.21 mlfmin 
per g m the I^;te wall Ip = NSI IT;lhls 3. Fig. ?I and Ihe 
rare-prcswrc pruducl was 7.987 + I.699 mm Hg.bealslmm 
In ~a,alrenl~ with hyperlrophic cardmmyopzlhy. regional 
my&dial blood flow m lie inlervenlri&r seplum wzs 
hisher than in the free wall Ii.14 t 0.43 versus O.YU 2 
O.jS mllmin per S. p i 0.05’ (Table 3. Fig. 2). However. 
baseline Row valuc~ in paliemr with hypertrophlc cardmmy- 
upsthy were no! strmsr~cally dr?crcnt from those in control 
suhjccrx The ratcqxeuure prod& was 9.641 2 3,234 mm 
Hg,beat\lmin (p = NS vcra~ cnnlrnl wbjcctsl. 
Bnwli~w wcw~~l I awzri~ ri~ti~rrvr~.~ I( 01 rinrilw b rhr 
wnrml gro,,,, and r/w proap urrl1 bwcwoph!~~ wdh~.ry- 
qwl~y, both in the repturn (97.7 ? Il.3 verws 95.6 2 
30. I mm Hg.mmml ‘.g-’ p 7 NSI and the free ~111(103.0 
t 23.2 vcrws 122.4 ? 40.0 mm Hg~mrn~ml~‘.g~‘. p = NS) 
Dipyridamulr inlwion. Dipyrrdamolc mfuws proved tc 
he sufc both in control .ubJccrs and in pawnlr with hyper- 
lruphic cardiomynpsthy. None ol the control subjects cxpe- 
rienccd any cardmvasular symptom or showed ECG 
changes during or alter dipyridamole admmrslrauon. Eishhl 
palicntb urlh hypertrophic cardmmyapathy WWenls I, 4.6. 
II. 14. 15. 17 and 23) cxpcriunccd chest pain after drug 
admmrsrdtmn. Sgmficant ST scgrnent depresson Irectdm- 
car or downsloping Xl.1 mV X0 mr ;fer the J point) 
occurred in IWO of the pawnrr who experienced <chest pain 
abler drug admmwauon and al50 in a third palienl who did 
not ehpericncc chal pain after dipyridnmolc infuwn IPa- 
benlb I I, I4 and 9. rerpecWelyl. The eight patients with 
Figure 1. Poshron emission Lomogrdphic images 0W I equilibrium 
sam) al myocardral nitrogen-llamnwnia uptake in one control 
rubjcct map pair), one palirnr wh hypenmphic cardiomyopalhy 
lHCMl wirhout a hirrory of chest pain (middle pair) and ace padem 
with hypenmphic cardiamyopelhy wilh a history d chart pain 
~botlom pirl obmmed at bcehne srudy CkW and aflcr dipyridamole 
mlusion tO.56 mdkg over 4 mm, ,righ,,. In each image. the a”- 
reraseptvl wall is in Ihe 9 m I o’rkxk pcrition and rhc free wall ofrhe 
left ventricle II m Ihe I lo6o’clock pmilion. The remainingopaares 
is the plane of the mwal vake. In rhe comrol subject and the padenl 
whh hp@rophlc cardmmyopathy withour a h;imry ofchcrl pain. 
mvorardial lmcer umake is homoeeneour bath at RI! and after 
rmdy was I. I I aid t.W mlinm peri in the ICPW” and free wall and 
wrcxoJ IU I .75 and I 7fi mllmin perg. respeelively, after dfpyrida- 
mole mfusion. which did nor induce rympromr or ECG changes. In 
the parrem wh hypemophic cardiamyopalhy wirh a history of 
chcrr pairs myocardial nacer uprake was homogeneous at buelinc 
wdy and became heerqencour after dipyndamak mfusion. which 
Induced chest pan and ST sqmen, depresrion. Uplake I” rhe 
ieprum ,~rrm.I was s,emficanlly lew than lhar in rhe free wall. In 
,h,\ p&en,. myorardu, blood flow a! barehnc srudy war 1.53 and 
I IY mhn per a m Ihc .cptum and free wall. res~ecrwel~. Afrer 
Cemparkan brtaern palien& uilh hgputrophir cardiomy. 
opdthj rith and nithoot a hisfor! of chest pain. When 
p;s,,cnl, \i,lh d hworj oichcsl pa,,, (Y of 231 WCK U,“Iparcd 
,1.57 q r!.?r WC”1 1.40 i 0.58 rnl~rni” per 5. p = NS,. 
Rqwnal wmnary rw~ta”cc afwr dipyndamole w+s alw 
cnmpnrahle 111 fhc two whgroupc LI;L~~ 2nd without a history 
of cherl pun. both in Ike reptum (65 3 z 25.6 versu 63 2 + 
XlImm Hg mwml ‘.g-‘. p = NSI and inrhefree wall166.7 
three patients who had an absolute reduction in coronary 
Row below baseline values after dipyridamole (Patients 4.9 
and 14) were in the group with a history of chert pain. In all 
three cases. Row in the ~eprom was absolutely reduced by 
dipyridnmolc and in two it was also reduced m the free wall. 
No statistically significant differences were found be- 
tween patients with hywrtroohic cardiomvooatby with and 
without rystobc ante&r mot/on of the mitral valve in terms 
of reaional myocardial Row both at baseline study and after 
dipyhdamole: 
Discussion 
Compariwn with previous reports. Several repons from 
d&en! groups have led to the belief that in patients with 
hypenrophic cardiomyopathy. the coronary vasculatore is 
abnormal. Anatomtcally abnormal intramural coronary ar- 
teries (thickened vessel wall and decreased luminal sire) 
have been found (3) in >gtlW of patients with hypenmphic 
cardiomyopathy examined at necmpsy. These abnormalities 
were found to be equally severe in patients with and without 
left ventricular obstruction. suggesting that this alteration is 
not directly related to increased intramyocardial wall tension 
(3). In addition, although the abnormal arteries were more 
frequently found in the interventricular septum. thev were 
also quite common in the anterior and posterior left venttic- 
ular free walls. 
The results of our study show that. in patients with 
“gum 1. tndirldual Yd”C5 of reptat nd 
free wall regmnal myoeardial bleed Aor 
(RMBFI at basetine (Bar) study and alter 
dipyridamote tlJ8pt infusion in paoenrr 
,: irb +pszropbic cardiomyopathy tHCMI 
without (lop purlrt and aith lbettom p&n. 
etst a history of chest pam. Patients with 
hygnrnphic cardiamyopaby with a bir- 
tr’: of chest pin are characterized by a 
ingher baxline regional myocardial blood 
Rw in the septum and free watt. After 
dipyridamotr. three padems whr h;d a 
hi$ory of chest pain showed do absolu!r 
reduction in regional w oxdial blood 
Row below baseline values I” the ~,xum 
tn = 3) and free wall In = 1,. 
hypertrophic cardiomyopathy, coronary vasodilalion after 
dipyridamole is equally impaired in the hypenrophied inter- 
ventncular septum and the nonhypertrophied left ventricular 
free wall. These anatomic and functional ohnormalities of 
the corooarv tree, which also occur in wocardial regions 
nor affected by macroscopic hypertrophy. might be an 
“independent marker” of hypenrophic wdiomyopathy (3). 
In addition. our data are in agreement and expand the 
preview observations of Cannon et al. (2.10) regarding the 
occurrence of ischemia in patients with hypenrophic cardio- 
myopathy in whom a reduced increment to great cardiac vein 
Bow war measured during rapid atrial pacing. In our present 
study, three of the patients with hypertmphic cardiomyop- 
athy who had e history of chest pain had an absolute 
reduction of regional myocardtal blood Row below the 
baseline value alter d,pl,ridztmole (Fig. 3). All three patients 
had a normal coronary tree on aoaioaraphy. In all three 
cases, Row was absolutely reduced in the sepium and m two 
it was also reduced in the free wall. Thus. ischemia can 
occur in myocardial regions that are spared by gross Lyper- 
trophy. This findinr might explain the “extensive transmural 
s&s” that have been found in nonhypertrophied myocar- 
dial regions (:I. 
When purims wirh (I lirrory ofchtw pain were coapand 
wirh those’ wirhorrr wch (1 hirroq, no obvious differences 
could be found with regard to age. gender. echocardio- 
graphic measurements. heart rate and arterial blood pres- 
sore. However. the patients with a history of chest pain had 
BASELtNE 
a higher baseline regional myocardial blood flow and a lower 
regional coronary rwstawc both m the acpwm anJ I” the 
free wall(Fin. 4). Thisfindingisinaprcement with the hieher 
baseline gr& cardiac veinRow rc~orted in these p&ntr 
12). 
Oarresulrs arc in conw~~~(ll wit/, rhnse d Growr-McKny 1’1 
al. !I/). who fnund 1 rcduccd nitrogen-13 anmonia conccn- 
tration in the scptun~ compared with the free wail of the left 
ventticle in patients with hypenroph!c cardiomyopathy \ad- 
ied at rest. However. 3 of the IO patient: cnrollcd m thw 
study had a history of hypenhyroidism and 9 patxcntr were 
studied during phammcolo@c trea!ment wth either a beta- 
adrcncrgic blocking agent or verapamil. lr additton. the 
discrepancy between results could be explaineli. at Icat !n 
part. by the worse performances of the powron tomograph 
used in their study (ECAT il. CTI). which has a spalml 
resolutiw. two time\ worse than that of our machine. A< a 
consequence. regional d&‘crcnccr in thickccrs Ihal arc 
present in asymmetric hypcnrophi: cardiomyopathy. will 
determine B better recovery of cc~unt~ (which is mainly 
dependent on the spatial resolution of the tomograph) from 
the thicker xptum than from the thmncr left ventricular free 
wail. In turn. this impow a heavy correction for the parnal 
volume efTect. which could lead to a final werotimat~on of 
radioactivity in the nonhypenrophied re:ions and a relatwe 
underevimatioa of w;:al radioactwu\. 
Coronan vamdilator rewve in hroeriroohic cardiomvoo- 
athy. Afte;dippridamolr. coronary ~~nt&c in the v$~m 
decreased hv 38% in patient\ withnzt a h&tow ofche?t vain. 
where% it decrcared’b) only 14% m those !&lh a hwo& of 
Figure 4. Mern rqmnal myocard,al blood Row IRMBF) ,tq w, 
and coronary re*,rmnce ICOR. RES., Rwttcm pan&, at baseline 
wdy snd .&cr dqyridamole m paoents with hypertrophic cardio- 
myopathy wh and without a chest pan history. Free wall regional 
myocardirl hlwd llow 1s signifxandy highr at baselifie study in 
pIIIcl!Is ulrh a hlrtory Of Cixll pain. Baseline regional coronary 
rewance 15 ngni6cantly lower in patient, with a history of chest 
pan both in OK wptum and Ihe free wall. ‘p < 0.05; “p < 011. 
chat pain (p c1 0.05). Coronary r&lance in the free wall 
dccrcaced by 45% in patients without and by 27% in those 
wth a history of chest pain (p = 0.06). These data indicate 
that although coronary vasodilatar reserve is reduced in all 
patient\ with hypcnrophic cardiomyopathy. the reduction is 
rignificandy more pronounced in patients who have a history 
of chest pan. Thi5 difference appears to bc related to a 
higher baseline Row rather than to a more severe reduction 
in maximal Row. It may he hypctherized that the reduced 
maximal Row in patient, with hypcnropbic cardiomyopathy 
is cawed by the structural abnormalities observed in the 
mtramural coronary arteries of these subjects which, by 
altermf the vessel wallilumen ratio. could produce arterio!ar 
dysfunction (12). 
Methodologic eonriderations. With regard IO the method 
used to mcasurc regional mvocardial blood flow. it is wonh 
notmg that our rentcoronar; flow values in normal subjects 
are comparable with those recently published by Krivoka. 
ptch et al. (131 using nitrogen-13 ammonia and positron 
emission tomoeraohv. Fitting the dynamic data with a two 
compartmcn~ I& kmetic model, they obtained an average 
p&t mvcaigation (O.YS + 0.23 mllmin per g, p = NSt. 
Unforrunately. flow data obtained after exe&e we% by 
the same aulhorr arc nol comparable with rhorc obraincd 
during pharmacologically Induced coronary vasodilarion in 
our study. 
Our normill value, are also comparable with those ob- 
tained by Bergmann et al. (14,. who measured myocardial 
blood Row by me,ms of oxygen45 labeled water and dy- 
namic positron emwion tomography. These authors repon 
an avcrap baseline myocardial blood Row of 0.94 + 
0.22 mVmin psr g m a group of normal SubJects. which is 
comparable with the average value for the whole myocar~ 
dium measured in our normal subjects. After dipyridamole 
10.56 mglkg mlravenaurlyL they repo< an averap myocar- 
dial blwd Row of 3.55 z I .I5 mUmin per g compared with 
2.60 t 0.91 mllmin per g in our study (p = NSt. 
The slightly lower although not siatisrically dii%rcnt Row 
rates measured with nitrogen-13 ammonia during pharmaca- 
logically Induced coronary vasodilalion could be panly ex- 
plained by the Row dependence ofammonia extraction (that is, 
the decrease in ammoniaextraction with increasing Raw rarest. 
The factor used in the present study fo cwrec~ for variable 
ammonia exlmclicm was derived from experiments in dogs. 
which could have Icd lo home degree ofuncertainty. However. 
any possible undereslimation of coronary flow al high Row 
rates would finally imply an undereslimation of Ihe actual 
impairment of coronary reserve in patients with hypenrophic 
cardiomyopathy as a rerult 4 the relatively greater underraring 
of maximal Row in control subjects. 
In conclusion. coronary vascdilamr reserve is abnormal in 
patients with arymmelric hypmtmphic cardiomyopathy ~1 
only in the hypxnropbied inlerventticular seplum but also in 
Ihc nonhypenrophicd left ventricular free wall. Thcx findings 
sugper~ that the abnormal coronary vasomotion in patients 
with b/penmphic cardiomyopathy is not necessarily sccwd- 
ary to myocardial hypenrophy but might be an “independent 
marker” of the disease and that myocardial ischemia could 
piay 0 majm nuti iii :b: ;;:L~.cx-:, ui ;Lls disca;. 
